AB PHARMA
Board
2 directors, last change in 2023Director (not named in the articles)
appointed by deed of 14-12-2023
term without a fixed end
listed in the 2024 annual accounts, filed on 29-08-2025
Director (not named in the articles)
appointed by deed of 14-12-2023
term without a fixed end
earlier enige bestuurder,voormalige zaakvoerder, until 14-12-2023
listed in the 2024 annual accounts, filed on 29-08-2025
Mandates through the years
2 names, the dashed line is todayBROUNS Hilde
Director (not named in the articles)
Director (not named in the articles)
ASSELBERGHS Caroline
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- BROUNS Hilde
- Director (not named in the articles), since before 31-12-2021
- Enige bestuurder,voormalige zaakvoerder, until 14-12-2023
- ASSELBERGHS Caroline
- Director (not named in the articles), appointed by deed of 14-12-2023, still in office
Control
Capital
- Contribution
- €20,000
- Shares
- 2,000
- Contribution per share
- €10
- Equity per share
- €243 in 2024
- Source
- 2024 annual accounts
Articles of association
deed of 14-12-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 16:00
- Dissolution ruleThe articles set when and by whom the company can be dissolved.
- “Beslissing algemene vergadering met inachtneming van door Wetboek van vennootschappen en verenigingen bepaalde…”